Takeda Revenue and Competitors
Estimated Revenue & Valuation
- Takeda's estimated annual revenue is currently $200.6M per year.
- Takeda's estimated revenue per employee is $195,324
- Takeda's current valuation is $45.9B. (January 2022)
Employee Data
- Takeda has 1027 Employees.
- Takeda grew their employee count by 5% last year.
Takeda's People
Name | Title | Email/Phone |
---|---|---|
1 | Head Epidemiology, Takeda Vaccines Business Unit . | Reveal Email/Phone |
2 | Head Insights and Analytics, Takeda R&D Data Sciences Institute | Reveal Email/Phone |
3 | VP, Head Rare Diseases, Europe & Canada | Reveal Email/Phone |
4 | VP National Sales and Accounts, GI | Reveal Email/Phone |
5 | Head Business Excellence | Reveal Email/Phone |
6 | SVP, U.S. Rare Disease Business Unit Lead | Reveal Email/Phone |
7 | Head Industrial Automation | Reveal Email/Phone |
8 | Director - Chief Financial Officer | Reveal Email/Phone |
9 | Director, State Government Affairs | Reveal Email/Phone |
10 | Associate Director, Strategic Insights Partner, GI Global Commercial | Reveal Email/Phone |
Takeda Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $13.1M | 65 | 30% | N/A | N/A |
#2 | $75.6M | 376 | 7% | N/A | N/A |
#3 | $23.9M | 119 | 13% | $35M | N/A |
#4 | $12.7M | 63 | -3% | N/A | N/A |
#5 | $5.4M | 27 | -25% | N/A | N/A |
#6 | $6M | 30 | -35% | N/A | N/A |
#7 | $6.6M | 33 | -8% | N/A | N/A |
#8 | $13.5M | 67 | -3% | N/A | N/A |
#9 | $186.3M | 927 | 19% | N/A | N/A |
#10 | $4.4M | 22 | -4% | N/A | N/A |
What Is Takeda?
In1781,Chobei Takeda I begins selling traditional Japanese and Chinese herbal medicines in Doshomachi , the medicine district of Osaka, Japan. Takeda’s founder gains a reputation for business integrity and quality products and services. These characteristics and values continue through the years and become embeded into our uncompromising corporate philosophy, which still guide us today.
keywords:N/AN/A
Total Funding
1027
Number of Employees
$200.6M
Revenue (est)
5%
Employee Growth %
$45.9B
Valuation
N/A
Accelerator
Takeda News
... ? The ouster of former Immunomedics exec Usama Malik created a CEO opening at Fore Biotherapeutics, which is taking aim at BRAF...
These data announcements follow completion of patient enrollment in Takeda's AURORA (TAK-620-302) study, focusing on LIVTENCITY for first-line...
These data announcements follow completion of patient enrollment in Takeda's AURORA (TAK-620-302) study, focusing on LIVTENCITY for first-line...
... ? The ouster of former Immunomedics exec Usama Malik created a CEO opening at Fore Biotherapeutics, which is taking aim at BRAF...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $384.5M | 1149 | 8% | N/A |
#2 | $201.6M | 1200 | 2% | N/A |
#3 | $312.5M | 1240 | N/A | N/A |
#4 | $268.9M | 1338 | 8% | N/A |
#5 | $300M | 1563 | 6% | N/A |